等待开盘 11-05 09:30:00 美东时间
+0.040
+0.22%
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
11-03 20:20
Keefe, Bruyette & Woods analyst Woody Lay maintains California BanCorp (NASDAQ:BCAL) with a Outperform and raises the price target from $19 to $21.
10-31 20:49
Southern Calif Bancorp (NASDAQ:BCAL) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.39 by 22.14 percent. This is a 45.45 percent increase over earnings of $0.33 per share
10-28 20:16
The latest update is out from BCAL Diagnostics Limited ( ($AU:BDX) ). BCAL Diag...
10-21 09:08
The latest announcement is out from BCAL Diagnostics Limited ( ($AU:BDX) ). BCA...
10-20 06:40
BCAL Diagnostics Limited ( ($AU:BDX) ) has issued an announcement. BCAL Diagnos...
09-24 09:58
The latest announcement is out from BCAL Diagnostics Limited ( ($AU:BDX) ). BCA...
08-29 11:48
The latest announcement is out from BCAL Diagnostics Limited ( ($AU:BDX) ). BCA...
07-30 07:57
Stephens & Co. analyst Andrew Terrell maintains California BanCorp (NASDAQ:BCAL) with a Equal-Weight and raises the price target from $18 to $19.
07-29 21:19
Southern Calif Bancorp (NASDAQ:BCAL) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.41 by 5.65 percent. This is a 104.76 percent increase over earnings of $0.21 per share
07-28 20:10